L-Tryptophan: What the Sleep, Mood, and Safety Evidence Actually Shows
Educational overview — not medical advice. Never combine tryptophan with SSRIs, MAOIs, or other serotonergic drugs without a clinician's guidance (serotonin-syndrome risk). This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Tryptophan is the amino-acid precursor to serotonin, which your body further converts to melatonin — a real, textbook pathway. Doses of 1 g or more modestly reduce nighttime wakefulness during sleep (Sutanto 2022); mood/depression evidence is thinner and pathway-plausible, not treatment-proven. And here's the safety story you should know before buying: in 1989, a contaminated production lot from one manufacturer — not the tryptophan molecule itself — caused an outbreak of eosinophilia-myalgia syndrome with over 1,500 documented cases and real deaths, which is exactly why the buying and dosing sections below take safety seriously.
As an Amazon Associate we earn from qualifying purchases. Ranked by verified cost per gram, never commissions.
Start here
Cost per ~1 g dose — one capsule vs two
Most tryptophan products are sold as 500 mg capsules, so reaching the ~1 g dose used in the sleep research takes two. One product, NOW Foods' 1,000 mg tablet, delivers the full dose in a single tablet:
| Item | Value |
|---|---|
| BulkSupplements | $0.17 |
| Nutricost | $0.25 |
| Source Naturals | $0.32 |
| NOW Foods | $0.33 |
| NOW Foods | $0.36 |
| Doctor's Best | $0.44 |
The pathway: tryptophan → serotonin → melatonin
L-tryptophan is an essential amino acid — your body cannot make it, so every gram comes from food or a supplement. Once absorbed, it can cross into the brain and be converted into serotonin, which your body further converts into melatonin, the hormone that signals night to your body clock. That two-step conversion is real, textbook biochemistry, and it's the whole reason tryptophan is marketed for both sleep and mood. But being upstream of two important molecules doesn't automatically mean supplementing it produces two proven benefits — the sleep evidence and the mood evidence are very different in strength, which is why we grade them separately below.
Sleep: real, modest, and dose-dependent
This is tryptophan's best-supported use. A 2022 systematic review, meta-analysis, and meta-regression pooling four controlled studies found that supplemental tryptophan reduced wake-after-sleep-onset (WASO) — time spent awake during the night, not how fast you fall asleep — by about 81 minutes per gram overall, and the 1 g or more subgroup was left with markedly less residual wake time (28.91 min WASO) than the under-1 g subgroup (56.55 min) — a statistically significant split (Sutanto 2022). Notably, the same review found tryptophan did not significantly change sleep-onset latency, total sleep time, or sleep efficiency in the pooled data — so this is a nighttime-wakefulness effect, not a "falls asleep faster" effect. An older but larger narrative review of 40 controlled trials over two decades reported that "L-tryptophan in doses of 1 g or more produces an increase in rated subjective sleepiness and a decrease in sleep latency" — working best in people with mild insomnia or a longer-than-average baseline sleep latency (Hartmann 1982). The full breakdown, including a third review on who tryptophan helps most, is on does tryptophan help you sleep?
Mood & depression: thin, pathway-plausible, not treatment-proven
Because serotonin genuinely matters for mood regulation, tryptophan gets marketed as a mood supplement — but the supplementation evidence doesn't support that leap. A 2016 systematic review and meta-analysis of adjunctive nutraceuticals for depression found "mixed results" for tryptophan specifically, unlike the substances (SAMe, methylfolate, omega-3, vitamin D) the authors concluded did have supportive evidence (Sarris 2016). And in a small depletion-challenge study of patients recently recovered from depression, acutely removing tryptophan from the diet had no statistically significant effect on mood symptoms, despite measurably changing sleep physiology — suggesting the pathway is real and measurable, but that manipulating it doesn't reliably move mood in this population (Haynes 2004). Appetite and carbohydrate-craving claims rest on an even thinner base: a classic review proposed a mechanism by which carbohydrate-rich meals raise brain tryptophan and serotonin, but it is a hypothesis-generating review, not a controlled trial of tryptophan supplements on food intake (Wurtman 1986). Bottom line: don't take tryptophan as a depression treatment or a weight-loss aid.
The safety story you should understand: the 1989 EMS epidemic
This is the single most important thing to know before buying tryptophan, so we're stating it plainly and up front rather than in a footnote. In 1989, an outbreak of eosinophilia-myalgia syndrome (EMS) — severe muscle pain with a striking rise in a type of white blood cell — sickened over 1,500 documented people in the US and elsewhere (Kilbourne 1992). Epidemiologic investigation traced the outbreak to tryptophan supplements from a single manufacturer, Showa Denko K.K.: a case-control study of patients who bought L-tryptophan exclusively from that company found a specific contaminated production lot ("lot 2") carried an adjusted odds ratio of 35.9 for developing EMS, far outweighing other proposed factors, and chemical analysis showed that lot had the highest concentration of a contaminant compound among the lots tested (Henning 1993). The outbreak caused real, documented deaths, not just illness (Marks 1990). The FDA restricted most OTC tryptophan sales for roughly a decade; the ban was later lifted as the contamination link to one manufacturer's process became clear and quality-specification standards for amino-acid supplements tightened industry-wide (Oketch-Rabah 2016). The honest conclusion, sourced rather than editorialized: this was a manufacturing contamination event, not a property of the tryptophan molecule itself, and modern pharmaceutical/food-grade L-tryptophan from a tested, reputable supply chain is considered safe by current regulatory standards. But it happened, it was serious, and you deserve the full account, not a defensive one-liner.
Serotonin syndrome: a real, separate, current risk
Distinct from the EMS history, there is a real and current interaction risk: combining tryptophan with SSRIs, SNRIs, MAOIs, tricyclic antidepressants, or other serotonergic drugs can trigger serotonin syndrome, a potentially fatal reaction involving altered mental status and autonomic dysfunction. A 2026 case report describes a fatal outcome in a patient on multiple serotonergic medications with reported (possible, not lab-confirmed) L-tryptophan use, illustrating the real-world stakes of this drug-class combination (Morena 2026). Never combine tryptophan with these medications without your prescriber's explicit guidance. Full dosing and safety detail is on the dosage guide.
Not the same as 5-HTP
Tryptophan and 5-HTP are different molecules at different points on the same pathway (tryptophan → 5-HTP → serotonin). This site does not recommend 5-HTP and does not cover its dosing or safety data here — see tryptophan vs 5-HTP vs melatonin for the honest distinction.
Frequently asked questions
What is L-tryptophan and what does it do?
An essential amino acid your body converts to serotonin, then melatonin. Taken mostly for sleep at ~1 g before bed, where the evidence is real but modest. Mood and appetite claims share the pathway but have much thinner supplementation evidence.
Is tryptophan safe? What about the 1989 scare?
The 1989 EMS outbreak (1,500+ cases, real deaths) was traced to a contaminant in one manufacturer's (Showa Denko) production lot, not the molecule itself. Modern pharmaceutical-grade tryptophan is considered safe. Separately, never combine it with SSRIs/MAOIs (serotonin-syndrome risk).
Related guides
- Melatonin — the downstream end of the same pathway, and the better-evidenced pick for sleep onset specifically
- GABA — a different calming-neurotransmitter route
- Glycine — another amino acid with modest sleep evidence
- L-Theanine — calm-focus amino acid, often stacked for sleep
- Magnesium for Sleep
- Ashwagandha for Sleep — a stress-driven route to better sleep
- Saffron for Depression — a mood supplement with better-studied evidence than tryptophan's
Sources
- Sutanto CN, Loh WW, Kim JE. "The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression." Nutrition Reviews. 2022. PMID: 33942088
- Hartmann E. "Effects of L-tryptophan on sleepiness and on sleep." Journal of Psychiatric Research. 1982. PMID: 6764927
- Silber BY, Schmitt JA. "Effects of tryptophan loading on human cognition, mood, and sleep." Neuroscience and Biobehavioral Reviews. 2010. PMID: 19715722
- Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M. "Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses." The American Journal of Psychiatry. 2016. PMID: 27113121
- Haynes PL, McQuaid JR, Kelsoe J, Rapaport M, Gillin JC. "Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals." Journal of Affective Disorders. 2004. PMID: 15555723
- Wurtman RJ, Wurtman JJ. "Carbohydrate craving, obesity and brain serotonin." Appetite. 1986. PMID: 3527063
- Kilbourne EM. "Eosinophilia-myalgia syndrome: coming to grips with a new illness." Epidemiologic Reviews. 1992. PMID: 1289111
- Henning KJ, Jean-Baptiste E, Singh T, Hill RH, Friedman SM. "Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan." The Journal of Rheumatology. 1993. PMID: 8474064
- Marks DR. "A case of L-tryptophan-induced eosinophilia-myalgia resulting in death." Connecticut Medicine. 1990. PMID: 2265542
- Oketch-Rabah HA, Roe AL, Gurley BJ, Griffiths JC, Giancaspro GI. "The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of l-Tryptophan and l-Citrulline." The Journal of Nutrition. 2016. PMID: 27934657
- Morena D, Colonna SS, Santurro A, Scopetti M, Tortorella A, Fineschi V. "The interplay between serotonin syndrome and syndrome of inappropriate antidiuresis: a fatal case of acute hyponatremia during treatment with duloxetine, chlorphenamine, amitriptyline, and L-tryptophan." Therapeutic Advances in Psychopharmacology. 2026. PMID: 41732713
- Full product dataset: /tryptophan/cost-by-brand.json (CC BY 4.0).